The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...

Dr. Debu Tripathy discusses the FDA approval of Enhertu in unresectable or metastatic hormone receptor HR+, HER2-low or -ultralow breast cancer.

New, less damaging treatments are giving some patients the choice to try to preserve their ability to have children after cancer.

"I was surprised at how little was known about the role of research nursing" “Research nursing seems an easy job – sitting at ...